Showing 1 - 20 results of 33 for search 'Takashi Niizeki', query time: 0.05s
Refine Results
-
1
-
2
-
3
-
4
Successful Treatment with Hepatic Arterial Infusion Chemotherapy in a Breast Cancer Patient with Multiple Liver Metastases Who Declined Systemic Therapy by Takaaki Masuda, Osamu Niizeki, Takashi Niizeki, Kenji Fujiyoshi, Yuki Ando, Hiroshi Niizeki, Koshi Mimori
Published 2021-09-01
Article -
5
Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma by Shigeo Shimose, Shunji Koya, Takumi Kawaguchi, Keisuke Hirota, Sachiyo Yoshio, Takashi Niizeki, Hiroo Matsuse, Takuji Torimura
Published 2021-10-01
Article -
6
-
7
Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast‐enhanced ultrasound by Naoki Kamachi, Masahito Nakano, Shusuke Okamura, Takashi Niizeki, Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Yu Noda, Ryoko Kuromatsu, Hironori Koga, Takuji Torimura
Published 2022-02-01
Article -
8
Impact of Decorin on the Physical Function and Prognosis of Patients with Hepatocellular Carcinoma by Takumi Kawaguchi, Sachiyo Yoshio, Yuzuru Sakamoto, Ryuki Hashida, Shunji Koya, Keisuke Hirota, Dan Nakano, Sakura Yamamura, Takashi Niizeki, Hiroo Matsuse, Takuji Torimura
Published 2020-03-01
Article -
9
Percutaneous Radiofrequency Ablation with or without Chemolipiodolization for Hepatocellular Carcinoma: A Propensity-Score-Matched Analysis by Kota Takaki, Masahito Nakano, Kazuta Fukumori, Yoichi Yano, Yuki Zaizen, Takashi Niizeki, Kotaro Kuwaki, Masaru Fukahori, Takahiko Sakaue, Sohei Yoshimura, Mika Nakazaki, Takuji Torimura
Published 2022-03-01
Article -
10
Clinical Importance of Regimens in Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Macrovascular Invasion by Takashi Niizeki, Hideki Iwamoto, Tomotake Shirono, Shigeo Shimose, Masahito Nakano, Shusuke Okamura, Yu Noda, Naoki Kamachi, Suzuki Hiroyuki, Miwa Sakai, Ryoko Kuromatsu, Hironori Koga, Takuji Torimura
Published 2021-09-01
Article -
11
Case Report: Exacerbation of varices following atezolizumab plus bevacizumab treatment of hepatocellular carcinoma: A case series and literature review by Hiroyuki Suzuki, Hideki Iwamoto, Hideki Iwamoto, Shigeo Shimose, Takashi Niizeki, Tomotake Shirono, Yu Noda, Naoki Kamachi, Taizo Yamaguchi, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi
Published 2022-07-01
Article -
12
Usefulness of a novel transarterial chemoinfusion plus external‐beam radiation therapy for advanced hepatocellular carcinoma with tumor thrombi in the inferior vena cava and right... by Tomotake Shirono, Hironori Koga, Takashi Niizeki, Hiroaki Nagamatsu, Hideki Iwamoto, Shigeo Shimose, Masahito Nakano, Shusuke Okamura, Yu Noda, Naoki Kamachi, Ryoko Kuromatsu, Etsuyo Ogo, Takuji Torimura
Published 2022-08-01
Article -
13
Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching by Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki, Masatoshi Tanaka, Tomotake Shirono, Etsuko Moriyama, Yu Noda, Masahito Nakano, Hideya Suga, Ryoko Kuromatsu, Takuji Torimura, Hironori Koga, Takumi Kawaguchi
Published 2023-09-01
Article -
14
Therapeutic Outcomes and Prognostic Factors of Unresectable Intrahepatic Cholangiocarcinoma: A Data Mining Analysis by Tomotake Shirono, Takashi Niizeki, Hideki Iwamoto, Shigeo Shimose, Hiroyuki Suzuki, Takumi Kawaguchi, Naoki Kamachi, Yu Noda, Shusuke Okamura, Masahito Nakano, Ryoko Kuromatu, Hironori Koga, Takuji Torimura
Published 2021-03-01
Article -
15
Primary Treatment with Molecular‐Targeted Agents for Hepatocellular Carcinoma: A Propensity Score‐matching Analysis by Masahito Nakano, Ryoko Kuromatsu, Takashi Niizeki, Shusuke Okamura, Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Yu Noda, Naoki Kamachi, Hironori Koga, Takuji Torimura, The Kurume Liver Cancer Study Group of Japan
Published 2020-08-01
Article -
16
Association between Adverse Events and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study by Shigeo Shimose, Hideki Iwamoto, Masatoshi Tanaka, Takashi Niizeki, Masahiko Kajiwara, Satoshi Itano, Etsuko Moriyama, Tomotake Shirono, Yu Noda, Naoki Kamachi, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi
Published 2022-09-01
Article -
17
Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma by Hideki Iwamoto, Takuji Torimura, Toru Nakamura, Osamu Hashimoto, Kinya Inoue, Junichi Kurogi, Takashi Niizeki, Reiichiro Kuwahara, Mitsuhiko Abe, Hiromori Koga, Hirohisa Yano, Robert S. Kerbel, Takato Ueno, Michio Sata
Published 2011-03-01
Article -
18
Durable complete response is achieved by balloon‐occluded transcatheter arterial chemoembolization for hepatocellular carcinoma by Tomotake Shirono, Hideki Iwamoto, Takashi Niizeki, Shigeo Shimose, Akira Kajiwara, Hiroyuki Suzuki, Naoki Kamachi, Yu Noda, Shusuke Okamura, Masahito Nakano, Ryoko Kuromatsu, Kenta Murotani, Hironori Koga, Takuji Torimura
Published 2022-09-01
Article -
19
The impact of curative conversion therapy aimed at a cancer‐free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab by Shigeo Shimose, Hideki Iwamoto, Tomotake Shirono, Masatoshi Tanaka, Takashi Niizeki, Masahiko Kajiwara, Satoshi Itano, Yoichi Yano, Satoru Matsugaki, Etsuko Moriyama, Yu Noda, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi
Published 2023-06-01
Article -
20
Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Cohor... by Shigeo Shimose, Takumi Kawaguchi, Hideki Iwamoto, Masatoshi Tanaka, Ken Miyazaki, Miki Ono, Takashi Niizeki, Tomotake Shirono, Shusuke Okamura, Masahito Nakano, Hideya Suga, Taizo Yamaguchi, Yoshinori Yokokura, Kazunori Noguchi, Hironori Koga, Takuji Torimura
Published 2020-04-01
Article